Updates are available Correction dated 2020-01-09
Click to view Correction: https://doi.org/10.1186/s13075-019-2094-5
-
Authors
,
Colafrancesco, Serena
Manara, Maria
Bortoluzzi, Alessandra
Serban, Teodora
Bianchi, Gerolamo
Cantarini, Luca
Ciccia, Francesco
Dagna, Lorenzo
Govoni, Marcello
Montecucco, Carlomaurizio
Priori, Roberta
Ravelli, Angelo
Sfriso, Paolo
Sinigaglia, Luigi
- License Information
-
More Information
Article History
Received: 16 May 2019
Accepted: 3 October 2019
First Online: 11 December 2019
Change Date: 9 January 2020
Change Type: Correction
Change Details: Following publication of the original article [1], it was brought to our attention that the AOSD Consensus Group was incorrectly tagged and therefore not searchable. The publishers apologize for this error.
Ethics approval and consent to participate
: Not applicable
: Not applicable
: SC received consulting fees from Swedish Orphan Biovitrum and Novartis. MM, AB, and TS received consulting fees from Novartis. RP received consulting fees from Swedish Orphan Biovitrum and Novartis. AR received grant support and/or speaking or consultant fees from Angelini, AbbVie, Bristol-Myers Squibb, Novartis, Pfizer, Reckitt-Benckiser, Roche, and Johnson & Johnson. LS received consulting fees from Novartis. CM received consulting fees from Novartis. LD received consultation honoraria from Abbvie, Amgen, Biogen, Bristol-Myers Squibb, Celltrion, Novartis, Pfizer, Sanofi-Genzyme, and Sobi. PS received research support/grants for presentations and advisory boards from Novartis and Sobi. All other authors declare that they have no competing interests.
